Roche Diabetes Care and Sweetlings – Sustainable Access to Care
Roche Diabetes Care India (RDC India) has partnered with Hirabai Cowasji Jehangir Medical Research Institute (HCJMRI) (Sweetlings, run by HCJMRI and Jehangir Hospital, Pune) to give children with type 1 diabetes with holistic medical care and therapy adherence assistance (T1D). This is part of RDC India’s commitment to providing individuals with diabetes in India with more sustainable access to care.
Not only does India have the world’s second-largest number of adults with diabetes (77 million), but roughly 57 percent of the country’s population is still undiagnosed. India also ranks first among the top ten nations in terms of the expected number of children and adolescents (0–14 years) with type 1 diabetes1. This information highlights the important need for blood glucose testing and continuous monitoring to increase awareness, early diagnosis, and therapy adherence.
“The meaning of access to care goes beyond just providing medical treatment and includes creating an eco-system that enables early diagnosis and treatment along with the required socio-economic support critical to therapy adherence,” said Omar Sherief Mohammad, Cluster Head India Middle East and Africa, RDC. Biases that exist owing to a lack of awareness are often at the basis of challenges affecting access to care. We must first break these boundaries in order to make a substantial effect.”
“In Sweetlings, we’ve discovered a partner who shares our passion for this mission. We intend to expand our collaboration in order to co-create a long-term model that allows us to perform real-world evidence studies to better understand the health economic impact. This will help to highlight the country’s diabetes burden as well as access impediments to treatment,” he added.
“The collaboration with Roche Diabetes Care will enable us to extend our holistic programme to more children with T1D so that they can have fuller and happier lives,” stated Dr. Anuradha Khadilkar, Deputy Director of the HCJMRI. For young children and their families, managing type 1 diabetes is a 24-hour job. This is why, for over a decade, we’ve worked directly with poor children and youth (aged 10 to 21) to provide them with comprehensive medical, psychological, nutritional, and educational support.”
Over the last two decades, Sweetlings has worked to raise awareness, provide education, and provide healthcare to disadvantaged children with T1D. They are also interested in research that is both socially and therapeutically responsible. Sweetlings has touched the lives of many families by providing them with support that goes beyond medical treatment, allowing them to live meaningful lives as contributing members of society. RDC India is assisting Sweetlings by donating 152 Accu-Chek Active blood glucose testing kits and 5600 Accu-Chek Active 50s test strip vials to aid support diagnosis, therapy adherence, and full medical care of children with T1D for a year.
Roche Diabetes Care
RDC just completed a pan-India programme to raise awareness about T1D under its award-winning campaign The DiaBeaters, as part of their continued efforts to maintain the continuum of treatment. This effort has touched the lives of 11000 youngsters in 11 states during the last two years. RDC India aided diabetes screening and awareness camps during World Diabetes Day 2021 by giving 15000+ blood glucometers, 100,000+ test strips, and hosting 650+ awareness sessions, affecting the lives of 2000+ diabetics. – Roche Diabetes Care India (RDC India) has partnered with Hirabai Cowasji Jehangir Medical Research Institute (HCJMRI) (Sweetlings, run by HCJMRI and Jehangir Hospital, Pune) to give children with type 1 diabetes with holistic medical care and therapy adherence assistance (T1D). This is part of RDC India’s commitment to providing individuals with diabetes in India with more sustainable access to care.
Not only does India have the world’s second-largest number of adults with diabetes (77 million), but roughly 57 percent of the country’s population is still undiagnosed. India also ranks first among the top ten nations in terms of the expected number of children and adolescents (0–14 years) with type 1 diabetes1. This information highlights the important need for blood glucose testing and continuous monitoring to increase awareness, early diagnosis, and therapy adherence.
“The meaning of access to care goes beyond just providing medical treatment and includes creating an eco-system that enables early diagnosis and treatment along with the required socio-economic support critical to therapy adherence,” said Omar Sherief Mohammad, Cluster Head India Middle East and Africa, RDC. Biases that exist owing to a lack of awareness are often at the basis of challenges affecting access to care. We must first break these boundaries in order to make a substantial effect.”
“In Sweetlings, we’ve discovered a partner who shares our passion for this mission. We intend to expand our collaboration in order to co-create a long-term model that allows us to perform real-world evidence studies to better understand the health economic impact. This will help to highlight the country’s diabetes burden as well as access impediments to treatment,” he added.
“The collaboration with Roche Diabetes Care will enable us to extend our holistic programme to more children with T1D so that they can have fuller and happier lives,” stated Dr. Anuradha Khadilkar, Deputy Director of the HCJMRI. For young children and their families, managing type 1 diabetes is a 24-hour job. This is why, for over a decade, we’ve worked directly with poor children and youth (aged 10 to 21) to provide them with comprehensive medical, psychological, nutritional, and educational support.”
Sustainable Access Care
Over the last two decades, Sweetlings has worked to raise awareness, provide education, and provide healthcare to disadvantaged children with T1D. They are also interested in research that is both socially and therapeutically responsible. Sweetlings has touched the lives of many families by providing them with support that goes beyond medical treatment, allowing them to live meaningful lives as contributing members of society. RDC India is assisting Sweetlings by donating 152 Accu-Chek Active blood glucose testing kits and 5600 Accu-Chek Active 50s test strip vials to aid support diagnosis, therapy adherence, and full medical care of children with T1D for a year.
RDC just completed a pan-India programme to raise awareness about T1D under its award-winning campaign The DiaBeaters, as part of their continued efforts to maintain the continuum of treatment. This effort has touched the lives of 11000 youngsters in 11 states during the last two years. RDC India aided diabetes screening and awareness camps during World Diabetes Day 2021 by giving 15000+ blood glucometers, 100,000+ test strips, and hosting 650+ awareness sessions, affecting the lives of 2000+ diabetics.
Read more Health CSR News on My CSR India.
